Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Merck, NIH Cannot Explain Higher Number Of AIDS Cases In HIV Vaccinated Individuals

This article was originally published in The Pink Sheet Daily

Executive Summary

In some instances, the vaccine may have led to an increase in HIV infections.

You may also be interested in...



Biotech Takes Electrifying Approach To Developing An HIV Vaccine

In the tumultuous quest to create an effective HIV vaccine, an approach that combines a DNA vaccine with a jolt of electricity looks to be a promising candidate in monkeys, but more data is needed in humans before breaking out the champagne, researchers say

Biotech Takes Electrifying Approach To Developing An HIV Vaccine

In the tumultuous quest to create an effective HIV vaccine, an approach that combines a DNA vaccine with a jolt of electricity looks to be a promising candidate in monkeys, but more data is needed in humans before breaking out the champagne, researchers say

Hemispherx Ampligen Filing Will Jumpstart NDA Clock

Biopharma accelerates evaluation of the Toll-like receptor-3 agonist as an adjuvant for HIV/AIDS and avian influenza vaccines.

Topics

UsernamePublicRestriction

Register

PS065479

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel